Skip to Content
You are currently on the new version of our website. Access the old version .

273 Results Found

  • Review
  • Open Access
37 Citations
5,498 Views
11 Pages

Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity

  • Ji-Hee Nam,
  • Jun-Ho Lee,
  • So-Yeon Choi,
  • Nam-Chul Jung and ,
  • Jie-Young Song,
  • Han-Geuk Seo and
  • Dae-Seog Lim
  • + 2 authors+ 0 author

Dendritic cells (DCs) are the most potent professional antigen-presenting cells (APCs) and inducers of T cell-mediated immunity. Although DCs play a central role in promoting adaptive immune responses against growing tumors, they also establish and m...

(This article belongs to the Special Issue Tumor Immunology & Immunotherapy)
  • Review
  • Open Access
1 Citations
692 Views
29 Pages

8 September 2026

Psoriasis is a chronic, relapsing skin disease driven by failed immune tolerance toward self-antigens and sustained IL-23/IL-17 signaling. Systemic drugs and biologics control disease in many patients, yet they do not restore lasting tolerance, and m...

(This article belongs to the Special Issue Skin Inflammation and Immunology: Vaccines, Immunomodulation, and Translational Therapeutics)
  • Article
  • Open Access
10 Citations
4,149 Views
18 Pages

Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator

  • María José Mansilla,
  • Iñigo González-Larreategui,
  • Neus Figa-Martín,
  • Jaume Barallat and ,
  • Federico Fondelli,
  • Ares Sellés-Rius,
  • Bibiana Quirant-Sánchez,
  • Aina Teniente-Serra and
  • Eva Martínez-Cáceres
  • + 4 authors+ 0 author

The use of autologous tolerogenic dendritic cells (tolDC) has become a promising strategy to re-establish immune tolerance in autoimmune diseases. Among the different strategies available, the use of vitamin D3 for the generation of tolDC (VitD3-tolD...

(This article belongs to the Special Issue Tolerogenic Cell-Based Therapy: Where We Stand?)
  • Review
  • Open Access
13 Citations
4,928 Views
13 Pages

18 February 2025

Ultraviolet (UV) radiation has profound effects on the immune system, including the induction of tolerogenic dendritic cells (DCs), which contribute to immune suppression and tolerance. This review explores the roles of conventional CD11c⁺ DCs,...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms in Immune Regulation)
  • Review
  • Open Access
39 Citations
11,689 Views
27 Pages

Myeloid regulatory cell-based therapy has been shown to be a promising cell-based medicinal approach in organ transplantation and for the treatment of autoimmune diseases, such as type 1 diabetes, rheumatoid arthritis, Crohn’s disease and multiple sc...

(This article belongs to the Special Issue Tolerogenic Cell-Based Therapy: Where We Stand?)
  • Review
  • Open Access
122 Citations
11,067 Views
16 Pages

Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease

  • Giuseppe Cappellano,
  • Cristoforo Comi,
  • Annalisa Chiocchetti and
  • Umberto Dianzani

Tolerogenic vaccines are aimed at inhibiting antigen-specific immune responses. Antigen-loaded nanoparticles (NPs) have been recently emerged as ideal tools for tolerogenic vaccination because their composition, size, and capability of loading immuno...

(This article belongs to the Special Issue Cell-Biomaterial Interaction 2019)
  • Review
  • Open Access
37 Citations
8,207 Views
25 Pages

21 October 2019

Tolerogenic dendritic cells (tolDCs) are central players in the initiation and maintenance of immune tolerance and subsequent prevention of autoimmunity. Recent advances in treatment of autoimmune diseases including systemic lupus erythematosus (SLE)...

(This article belongs to the Special Issue The Molecular and Cellular Basis for Lupus)
  • Article
  • Open Access
13 Citations
6,366 Views
11 Pages

Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells

  • Tobias Roider,
  • Michael Katzfuß,
  • Carina Matos,
  • Katrin Singer and ,
  • Kathrin Renner,
  • Peter J. Oefner,
  • Katja Dettmer-Wilde,
  • Wolfgang Herr,
  • Ernst Holler and
  • Katrin Peter
  • + 6 authors+ 1 author

11 December 2016

Antithymocyte globulin (ATG) is used in the prevention of graft-versus-host disease during allogeneic hematopoietic stem cell transplantation. It is generally accepted that ATG mediates its immunosuppressive effect primarily via depletion of T cells....

(This article belongs to the Special Issue Advances in Cell Transplantation)
  • Article
  • Open Access
12 Citations
4,759 Views
16 Pages

Elucidating the Role of Ezh2 in Tolerogenic Function of NOD Bone Marrow-Derived Dendritic Cells Expressing Constitutively Active Stat5b

  • Echarki Zerif,
  • Farhan Ullah Khan,
  • Ahmed Aziz Raki,
  • Véronique Lullier and ,
  • Denis Gris,
  • Gilles Dupuis and
  • Abdelaziz Amrani
  • + 2 authors+ 0 author

4 September 2020

Tolerogenic dendritic cells (toDCs) are crucial to controlling the development of autoreactive T cell responses and the prevention of autoimmunity. We have reported that NOD.CD11cStat5b-CA transgenic mice expressing a constitutively active (CA) form...

(This article belongs to the Special Issue Dendritic Cells—Conductors and Activators of the Immunological Orchestra)
  • Article
  • Open Access
30 Citations
7,217 Views
21 Pages

Role of the p38 MAPK/C/EBPβ Pathway in the Regulation of Phenotype and IL-10 and IL-12 Production by Tolerogenic Bone Marrow-Derived Dendritic Cells

  • Chantal Guindi,
  • Alexandre Cloutier,
  • Simon Gaudreau,
  • Echarki Zerif and ,
  • Patrick P. McDonald,
  • Olga Tatsiy,
  • Claude Asselin,
  • Gilles Dupuis,
  • Denis Gris and
  • Abdelaziz Amrani
  • + 5 authors+ 0 author

7 December 2018

Dendritic cells (DCs) play a major role in innate and adaptive immunity and self-immune tolerance. Immunogenic versus tolerogenic DC functions are dictated by their levels of costimulatory molecules and their cytokine expression profile. The transcri...

  • Article
  • Open Access
2 Citations
2,110 Views
24 Pages

Deinoxanthin-Enriched Extracellular Vesicles from Deinococcus radiodurans Drive IL-10–Dependent Tolerogenic Programming of Dendritic Cells

  • Jeong Moo Han,
  • Jaeyoon Lim,
  • Woo Sik Kim,
  • Bo-Gyeong Yoo and ,
  • Jong-Hyun Jung,
  • Sangyong Lim and
  • Eui-Baek Byun
  • + 2 authors+ 0 author

12 September 2025

Extracellular vesicles (EVs) derived from bacteria are emerging as potent bioactive carriers that affect host immunity. Deinococcus radiodurans, an extremophilic bacterium with strong antioxidant capacity, produces EVs enriched in deinoxanthin (DX),...

(This article belongs to the Special Issue Redox Regulation of Immune and Inflammatory Responses)
  • Review
  • Open Access
10 Citations
7,396 Views
22 Pages

The Effects of Tamoxifen on Tolerogenic Cells in Cancer

  • Ros Akmal Mohd Idris,
  • Ali Mussa,
  • Suhana Ahmad,
  • Mohammad A. I. Al-Hatamleh and ,
  • Rosline Hassan,
  • Tengku Ahmad Damitri Al Astani Tengku Din,
  • Wan Faiziah Wan Abdul Rahman,
  • Norhafiza Mat Lazim,
  • Jennifer C. Boer and
  • Rohimah Mohamud
  • + 6 authors+ 1 author

17 August 2022

Tamoxifen (TAM) is the most prescribed selective estrogen receptor modulator (SERM) to treat hormone-receptor-positive breast cancer patients and has been used for more than 20 years. Its role as a hormone therapy is well established; however, the po...

(This article belongs to the Topic Immunotherapy and Targeted Therapy in Breast Cancer)
  • Review
  • Open Access
14 Citations
4,901 Views
31 Pages

Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review

  • Chiara Puricelli,
  • Elena Boggio,
  • Casimiro Luca Gigliotti,
  • Ian Stoppa and ,
  • Salvatore Sutti,
  • Roberta Rolla and
  • Umberto Dianzani
  • + 2 authors+ 0 author

Conventional therapies for immune-mediated diseases, including autoimmune disorders, transplant reactions, and allergies, have undergone a radical evolution in the last few decades; however, they are still not specific enough to avoid widespread immu...

(This article belongs to the Special Issue Recent Advances in Vaccine Delivery Systems)
  • Article
  • Open Access
3 Citations
4,789 Views
18 Pages

The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic Potential

  • Mohammed Ghiboub,
  • Matthew Bell,
  • Dovile Sinkeviciute,
  • Rab K. Prinjha and ,
  • Menno P. J. de Winther,
  • Nicola R. Harker,
  • David F. Tough and
  • Wouter J. de Jonge
  • + 3 authors+ 0 author

SP140 is an epigenetic reader protein expressed predominantly in immune cells. GWAS studies have shown an association between SP140 single nucleotide polymorphisms (SNPs) and diverse autoimmune and inflammatory diseases, suggesting a possible pathoge...

(This article belongs to the Special Issue Advances in Understanding Molecular Basis of Inflammatory Diseases)
  • Article
  • Open Access
3 Citations
2,553 Views
10 Pages

Bridging the Gap Between Tolerogenic Dendritic Cells In Vitro and In Vivo: Analysis of Siglec Genes and Pathways Associated with Immune Modulation and Evasion

  • Diahann T. S. L. Jansen,
  • Tatjana Nikolic,
  • Nicoline H. M. den Hollander,
  • Jaap Jan Zwaginga and
  • Bart O. Roep

31 October 2024

Background/Objectives: Dendritic cells (DCs) are master regulators of the adaptive immune response. Inflammatory DCs (inflamDCs) can prime inflammatory T cells in, for instance, cancer and infection. In contrast, tolerogenic DCs (tolDCs) can suppress...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
3 Citations
2,780 Views
15 Pages

Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner

  • Mats Van Delen,
  • Ibo Janssens,
  • Amber Dams,
  • Laurence Roosens and ,
  • Benson Ogunjimi,
  • Zwi N. Berneman,
  • Judith Derdelinckx and
  • Nathalie Cools
  • + 3 authors+ 0 author

2 December 2022

Although the global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still ongoing, there are currently no specific and highly efficient drugs for COVID-19 available, particularly in severe cases. Recent fi...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
560 Views
21 Pages

Treatment of Leukemic Blood Samples with Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Is Associated with Reduced Frequencies of Tolerogenic Dendritic Cells and Increased Cytotoxicity Against Autologous Blasts

  • Anne Hartz,
  • Lin Li,
  • Hazal Aslan Rejeski,
  • Elena Pepeldjiyska and ,
  • Elias Rackl,
  • Tobias Baudrexler,
  • Peter Bojko,
  • Jörg Schmohl,
  • Andreas Rank and
  • Helga Schmetzer
  • + 6 authors+ 1 author

Background: Acute myeloid leukemia (AML) is characterized by reduced antileukemic effector cells and increased immunosuppressive cell populations. Leukemia-derived dendritic cells (DCleu), generated from 18 leukemic whole blood (WB) ex vivo using &ls...

(This article belongs to the Section Immunology and Immunotherapy)
  • Article
  • Open Access
9 Citations
4,928 Views
13 Pages

Synthetic TGF-β Signaling Agonist-Treated Dendritic Cells Induce Tolerogenicity and Antirheumatic Effects

  • Ji-Soo Oh,
  • Sung-Uk Hwang,
  • Kyung-Eun Noh,
  • Jun-Ho Lee and ,
  • So-Yeon Choi,
  • Ji-Hee Nam,
  • Min-Seon Song,
  • Nam-Chul Jung,
  • Jie-Young Song and
  • Dae-Seog Lim
  • + 7 authors+ 2 authors

24 August 2022

The newly synthesized compound TGF-β signaling agonist (T74) is a small molecule associated with the TGF-β receptor signaling pathway. Tolerogenic dendritic cells (tDCs) have been used to examine immunosuppressive and anti-inflammatory effe...

(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
  • Review
  • Open Access
7 Citations
4,442 Views
15 Pages

25 November 2022

Insulin replacement is an available treatment for autoimmune type 1 diabetes mellitus (T1DM). There are multiple limitations in the treatment of autoimmune diseases such as T1DM by immunosuppression using drugs and chemicals. The advent of extracellu...

(This article belongs to the Section Molecular and Translational Medicine)
  • Review
  • Open Access
6 Citations
3,546 Views
19 Pages

Tolerogenic Therapies in Cardiac Transplantation

  • Laurenz Wolner,
  • Johan William-Olsson,
  • Bruno K. Podesser,
  • Andreas Zuckermann and
  • Nina Pilat

Heart transplantation remains the gold-standard treatment for end-stage heart failure, yet long-term graft survival is hindered by chronic rejection and the morbidity and mortality caused by lifelong immunosuppression. While advances in medical and d...

(This article belongs to the Special Issue Molecular Mechanisms in Organ Transplantation)
  • Review
  • Open Access
36 Citations
10,198 Views
14 Pages

Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease

  • Paolo Giuffrida,
  • Sara Cococcia,
  • Mariangela Delliponti,
  • Marco Vincenzo Lenti and
  • Antonio Di Sabatino

30 April 2019

Inflammatory bowel disease (IBD) is caused by a dysregulated immune response against normal components of the intestinal microflora combined with defective functioning of anti-inflammatory pathways. Currently, all therapies approved for IBD manipulat...

(This article belongs to the Special Issue The Molecular and Cellular Basis for Inflammatory Bowel Diseases (IBD))
  • Article
  • Open Access
8 Citations
4,504 Views
18 Pages

Mechanism of Action of Oral Salmonella-Based Vaccine to Prevent and Reverse Type 1 Diabetes in NOD Mice

  • Jacob Cobb,
  • Jeffrey Rawson,
  • Nelson Gonzalez,
  • Mahmoud Singer and ,
  • Fouad Kandeel and
  • Mohamed I. Husseiny
  • + 1 author+ 0 author

6 March 2024

A combination therapy of preproinsulin (PPI) and immunomodulators (TGFβ+IL10) orally delivered via genetically modified Salmonella and anti-CD3 promoted glucose balance in in NOD mice with recent onset diabetes. The Salmonella bacteria were modi...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Review
  • Open Access
  • Best Paper Award
617 Citations
24,869 Views
26 Pages

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis

  • Juanjuan Wang,
  • Ningning Zhu,
  • Xiaomin Su,
  • Yunhuan Gao and
  • Rongcun Yang

2 March 2023

The gut microbiota, including bacteria, archaea, fungi, viruses and phages, inhabits the gastrointestinal tract. This commensal microbiota can contribute to the regulation of host immune response and homeostasis. Alterations of the gut microbiota hav...

(This article belongs to the Collection Gut Microbiota-Derived Metabolites and Host Gut-Brain Communication)
  • Article
  • Open Access
17 Citations
4,910 Views
17 Pages

Retinoic Acid-Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases

  • Daniëlle ter Braake,
  • Naomi Benne,
  • Chun Yin Jerry Lau,
  • Enrico Mastrobattista and
  • Femke Broere

The current treatment of autoimmune and chronic inflammatory diseases entails systemic immune suppression, which is associated with increased susceptibility to infections. To restore immune tolerance and reduce systemic side effects, a targeted appro...

(This article belongs to the Collection Drug Delivery in The Netherlands)
  • Article
  • Open Access
18 Citations
4,597 Views
26 Pages

Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in Fcgr2b-/- Mice by Mediating Antigen-Specific Immune Tolerance

  • Phuriwat Khiewkamrop,
  • Chamraj Kaewraemruaen,
  • Chonnavee Manipuntee,
  • Chalathan Saengruengrit and ,
  • Numpon Insin,
  • Asada Leelahavanichkul,
  • Warerat Kaewduangduen,
  • Opor Sonpoung,
  • Kasirapat Ariya-anandech and
  • Patcharee Ritprajak
  • + 6 authors+ 1 author

Dendritic cells (DCs) are the most potent antigen-presenting cells that have multifaceted functions in the control of immune activation and tolerance. Hyperresponsiveness and altered tolerogenicity of DCs contribute to the development and pathogenesi...

(This article belongs to the Topic Nanomedical Research)
  • Review
  • Open Access
4 Citations
6,764 Views
26 Pages

Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells

  • Andrés París-Muñoz,
  • Odelaisy León-Triana,
  • Antonio Pérez-Martínez and
  • Domingo F. Barber

29 December 2023

The Helios protein (encoded by the IKZF2 gene) is a member of the Ikaros transcription family and it has recently been proposed as a promising biomarker for systemic lupus erythematosus (SLE) disease progression in both mouse models and patients. Hel...

(This article belongs to the Special Issue Technological and Molecular Advances in Systemic Lupus Erythematosus)
  • Review
  • Open Access
96 Citations
12,698 Views
21 Pages

Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity

  • Laura Passeri,
  • Fortunato Marta,
  • Virginia Bassi and
  • Silvia Gregori

Dendritic cells (DCs) dictate the outcomes of tissue-specific immune responses. In the context of autoimmune diseases, DCs instruct T cells to respond to antigens (Ags), including self-Ags, leading to organ damage, or to becoming regulatory T cells (...

(This article belongs to the Special Issue Tolerogenic Cell-Based Therapy: Where We Stand?)
  • Article
  • Open Access
16 Citations
4,231 Views
22 Pages

2 November 2023

Many treatments for autoimmune diseases, caused by the loss of immune self-tolerance, are broadly immunosuppressive. Dendritic cells (DCs) can be induced to develop anti-inflammatory/tolerogenic properties to suppress aberrant self-directed immunity...

(This article belongs to the Special Issue A Special Issue Celebrating the Career of Prof. Dr. Greg Lemke: Multiple Roles of the TAM Signaling Pathway in Physiological Systems)
  • Article
  • Open Access
12 Citations
5,360 Views
24 Pages

Sitagliptin Induces Tolerogenic Human Dendritic Cells

  • Marija Drakul,
  • Sergej Tomić,
  • Marina Bekić,
  • Dušan Mihajlović and ,
  • Miloš Vasiljević,
  • Sara Rakočević,
  • Jelena Đokić,
  • Nikola Popović,
  • Dejan Bokonjić and
  • Miodrag Čolić
  • + 5 authors+ 0 author

27 November 2023

Sitagliptin, an anti-diabetic drug, is a dipeptidyl peptidase (DPP)-4/CD26 inhibitor with additional anti-inflammatory and immunomodulatory properties. In this study, we investigated for the first time the effect of sitagliptin on the differentiation...

(This article belongs to the Section Molecular Pharmacology)
  • Review
  • Open Access
36 Citations
10,705 Views
65 Pages

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system and is considered to be the leading non-traumatic cause of neurological disability in young adults. Current treatments for MS comprise long-term immunosuppressant drugs an...

(This article belongs to the Special Issue Advances in Multiple Sclerosis Research—Series I)
  • Article
  • Open Access
3 Citations
1,245 Views
23 Pages

Exploring Sertoli Cells’ Innate Bulwark Role Against Infections: In Vitro Performances on Candida tropicalis Biofilms

  • Iva Arato,
  • Stefano Giovagnoli,
  • Luca Roscini,
  • Mario Calvitti and ,
  • Catia Bellucci,
  • Cinzia Lilli,
  • Elena Eugeni,
  • Stefano Brancorsini,
  • Gianluigi Cardinali and
  • Francesca Mancuso
  • + 6 authors+ 1 author

26 March 2025

This study aimed to evaluate the intrinsic in vitro performance of naïve porcine prepubertal Sertoli cells (SCs) and SCs loaded with blank poly(lactic acid) microparticles (MP) or amphotericin B poly(lactic acid) microparticles (AmB-MP) against...

  • Review
  • Open Access
65 Citations
7,939 Views
31 Pages

Glucocorticoids (GCs) are widely used to treat several diseases because of their powerful anti-inflammatory and immunomodulatory effects on immune cells and non-lymphoid tissues. The effects of GCs on T cells are the most relevant in this regard. In...

(This article belongs to the Special Issue Inflammatory/Immune Modulations by Old and New Glucocorticoids: From Cell to Medical Application)
  • Review
  • Open Access
17 Citations
7,930 Views
29 Pages

Unraveling the Biological Properties of Whey Peptides and Their Role as Emerging Therapeutics in Immune Tolerance

  • Laura Quintieri,
  • Anna Luparelli,
  • Leonardo Caputo,
  • William Schirinzi and ,
  • Federica De Bellis,
  • Leonardo Smiriglia and
  • Linda Monaci
  • + 2 authors+ 0 author

7 March 2025

Whey is a natural by-product of the cheese-making process and represents a valuable source of nutrients, including vitamins, all essential amino acids and proteins with high quality and digestibility characteristics. Thanks to its different techno-fu...

(This article belongs to the Topic Novel Therapeutic Nutrient Molecules, 2nd Volume)
  • Article
  • Open Access
2 Citations
965 Views
17 Pages

Background/Objectives: Multiple sclerosis (MS) imposes a substantial clinical, humanistic, and economic burden, and current disease-modifying therapies require lifelong administration without restoring immune tolerance. IMMUTOL, a tolerogenic gene th...

(This article belongs to the Special Issue Healthcare Economics, Management, and Innovation for Health Systems)
  • Article
  • Open Access
11 Citations
4,710 Views
18 Pages

Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic Cells

  • Ann-Katrin Menzner,
  • Tanja Rottmar,
  • Simon Voelkl,
  • Jacobus J. Bosch and ,
  • Dimitrios Mougiakakos,
  • Andreas Mackensen and
  • Yazid J. Resheq
  • + 2 authors+ 0 author

26 January 2021

Background and Aims: Induction of myeloid-derived suppressor cells (MDSC) is a critical step in immune cell evasion by different cancer types, including liver cancer. In the liver, hepatic stromal cells orchestrate induction of MDSCs, employing a mec...

(This article belongs to the Special Issue Mechanisms of Tumor Immune Evasion)
  • Review
  • Open Access
35 Citations
7,964 Views
17 Pages

Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?

  • Shaghayegh Baradaran Ghavami,
  • Hamid Asadzadeh Aghdaei,
  • Dario Sorrentino,
  • Shabnam Shahrokh and ,
  • Maryam Farmani,
  • Fatemeh Ashrafian,
  • Maria Pina Dore,
  • Shahrbanoo Keshavarz Azizi Raftar,
  • Seyed Mobin Khoramjoo and
  • Mohammad Reza Zali
  • + 5 authors+ 0 author

Inflammatory bowel diseases (IBDs) are immune-mediated, chronic relapsing diseases with a rising prevalence worldwide in both adult and pediatric populations. Treatment options for immune-mediated diseases, including IBDs, are traditional steroids, i...

(This article belongs to the Special Issue Immune Modulation of Mucosal Inflammation)
  • Article
  • Open Access
5 Citations
2,548 Views
12 Pages

NRF2 Plays a Crucial Role in the Tolerogenic Effect of Ethyl Pyruvate on Dendritic Cells

  • Suzana Stanisavljević,
  • Goran Stegnjaić,
  • Bojan Jevtić,
  • Mirjana Dimitrijević and ,
  • Đorđe Miljković,
  • Irena Lavrnja and
  • Neda Nikolovski
  • + 2 authors+ 0 author

Ethyl pyruvate (EP) is a redox-active compound that has been previously shown to be effective in restraining immune hyperactivity in animal models of various autoimmune and chronic inflammatory diseases. Importantly, EP has also been proven to have a...

(This article belongs to the Special Issue Advances in Molecular Research on Autoimmune Diseases, 2nd Edition)
  • Article
  • Open Access
12 Citations
3,235 Views
13 Pages

Tolerogenic IDO1+CD83− Langerhans Cells in Sentinel Lymph Nodes of Patients with Melanoma

  • Gianni Gerlini,
  • Paola Di Gennaro,
  • Nicola Pimpinelli,
  • Serena Sestini and
  • Lorenzo Borgognoni

Langerhans cells (LCs) are crucial regulators of anti-cancer immune responses. Cancer, however, can alter DCs functions leading to tolerance. The enzyme indoleamine 2,3-dioxygenase (IDO1) plays a crucial role in this process. In sentinel lymph nodes...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
59 Citations
8,431 Views
21 Pages

TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment

  • Roberta Angioni,
  • Ricardo Sánchez-Rodríguez,
  • Antonella Viola and
  • Barbara Molon

22 January 2021

Overcoming tumor immunosuppression still represents one ambitious achievement for cancer immunotherapy. Of note, the cytokine TGF-β contributes to immune evasion in multiple cancer types, by feeding the establishment of a tolerogenic environment...

(This article belongs to the Special Issue Effects of TGF-Beta on Cancer Cell Metabolism)
  • Feature Paper
  • Article
  • Open Access
50 Citations
8,429 Views
22 Pages

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

  • Laura Calvo-Barreiro,
  • Herena Eixarch,
  • Manuel Ponce-Alonso,
  • Mireia Castillo and ,
  • Rafael Lebrón-Galán,
  • Leyre Mestre,
  • Carmen Guaza,
  • Diego Clemente,
  • Rosa del Campo and
  • Carmen Espejo
  • + 6 authors+ 1 author

7 April 2020

Previous studies in experimental autoimmune encephalomyelitis (EAE) models have shown that some probiotic bacteria beneficially impact the development of this experimental disease. Here, we tested the therapeutic effect of two commercial multispecies...

(This article belongs to the Special Issue Gut Microbiota in Immunity and Inflammatory Diseases)
  • Article
  • Open Access
1 Citations
1,639 Views
15 Pages

PARP Inhibition Shifts Murine Myeloid Cells Toward a More Tolerogenic Profile In Vivo

  • Jose R. Pittaluga-Villarreal,
  • Casey M. Daniels,
  • Tara Capece,
  • Pauline R. Kaplan and ,
  • Martin Meier-Schellersheim and
  • Aleksandra Nita-Lazar
  • + 1 author+ 0 author

9 August 2025

The human Poly ADP-ribose Polymerase (PARP) family comprises 17 enzymes responsible for the transfer of ADP-ribose to proteins, forming poly- or mono-ADP-ribosylation. This post-translational modification regulates DNA repair and programmed cell deat...

(This article belongs to the Section Molecular Medicine)
  • Review
  • Open Access
33 Citations
9,832 Views
11 Pages

Hepatocyte growth factor (HGF)-signaling via Met can induce mitogenic, morphogenic, and motogenic activity in various cell types. Met expression in the immune system is limited to cells with antigen-presenting capacities, including dendritic cells (D...

(This article belongs to the Special Issue New aspects of the Hepatocyte Growth Factor/c-Met System)
  • Article
  • Open Access
6 Citations
1,919 Views
21 Pages

Physiological Oxygen Levels in the Microenvironment Program Ex Vivo-Generated Conventional Dendritic Cells Toward a Tolerogenic Phenotype

  • Antonia Peter,
  • Morgane Vermeulen,
  • Mats Van Delen,
  • Amber Dams and ,
  • Stefanie Peeters,
  • Hans De Reu,
  • Waleed F. A. Marei,
  • Zwi N. Berneman and
  • Nathalie Cools
  • + 4 authors+ 0 author

18 May 2025

Dendritic cells (DCs) are critical regulators of immune homeostasis, balancing tolerance and immunity through antigen presentation and T cell modulation. While the influence of hypoxia (<2% O2) on DC function in pathological settings is well-docum...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms in Immune Regulation)
  • Article
  • Open Access
8 Citations
2,690 Views
15 Pages

Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease

  • Kuan-Yuan Chen,
  • Wei-Lun Sun,
  • Sheng-Ming Wu,
  • Po-Hao Feng and ,
  • Chiou-Feng Lin,
  • Tzu-Tao Chen,
  • Yueh-Hsun Lu,
  • Shu-Chuan Ho,
  • Yueh-Hsi Chen and
  • Kang-Yun Lee
  • + 5 authors+ 0 author

20 May 2024

Background: Chronic obstructive pulmonary disease (COPD) is characterized, at least in part, by autoimmunity through amplified T helper 1 and 17 (Th1 and Th17) immune responses. The loss of immune tolerance controlled by programmed death-ligand 1 (PD...

(This article belongs to the Section Cellular Immunology)
  • Article
  • Open Access
27 Citations
5,629 Views
16 Pages

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis

  • Bibiana Quirant-Sánchez,
  • María José Mansilla,
  • Juan Navarro-Barriuso,
  • Silvia Presas-Rodríguez and ,
  • Aina Teniente-Serra,
  • Federico Fondelli,
  • Cristina Ramo-Tello and
  • Eva Martínez-Cáceres
  • + 3 authors+ 0 author

24 November 2021

Autologous antigen-specific therapies based on tolerogenic dendritic cells (tolDC) offer the possibility to treat autoimmune diseases by restoring homeostasis and targeting specifically autoreactive responses. Here, we explore the hypothesis that sys...

(This article belongs to the Topic Emerging Translational Research in Neurological and Psychiatric Diseases: From In Vitro to In Vivo Models)
  • Review
  • Open Access
19 Citations
9,199 Views
20 Pages

LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets

  • Zhiqing Xiang,
  • Xiangli Yin,
  • Leiyan Wei,
  • Manqing Peng and ,
  • Quan Zhu,
  • Xiaofang Lu,
  • Junshuang Guo,
  • Jing Zhang,
  • Xin Li and
  • Yizhou Zou
  • + 5 authors+ 0 author

4 February 2024

LILRB4, a myeloid inhibitory receptor belonging to the family of leukocyte immunoglobulin-like receptors (LILRs/LIRs), plays a pivotal role in the regulation of immune tolerance. LILRB4 primarily mediates suppressive immune responses by transmitting...

(This article belongs to the Special Issue Immune-Related Biomarkers: 2nd Edition)
  • Review
  • Open Access
34 Citations
13,325 Views
22 Pages

Macrophages act as immune scavengers and are important cell types in the homeostasis of various tissues. Given the multiple roles of macrophages, these cells can also be found as tissue resident macrophages tightly integrated into a variety of tissue...

(This article belongs to the Special Issue Human and Animal Monocytes and Macrophages in Homeostasis and Disease 2.0)
  • Review
  • Open Access
12 Citations
2,106 Views
12 Pages

Nanotechnology Approaches for Mitigating Biologic Immunogenicity: A Literature Review

  • Jouri Alanazi,
  • Fadilah Sfouq Aleanizy and
  • Fulwah Yahya Alqahtani

Biologic therapeutics, particularly monoclonal antibodies (mAbs), have revolutionized disease treatment paradigms; however, their clinical success is often hindered by immunogenicity. Host immune recognition of these biologics can induce anti-drug an...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Article
  • Open Access
712 Views
16 Pages

Differential Impact of the Endometrial Immune Environment in Fresh Versus Frozen Embryo Transfer

  • Nathalie Lédée,
  • Nada J. Habeichi,
  • Mona Rahmati,
  • Géraldine Dray and ,
  • Nicole Kerkhoven,
  • Eric Vicaut,
  • Abdourahmane Diallo,
  • Nino Guy Cassuto,
  • Lea Ruoso and
  • Marie Petitbarat
  • + 6 authors+ 1 author

30 June 2026

Background: The endometrial immune environment regulates maternal immune tolerance and plays a key role in embryo implantation. We investigated whether its impact on reproductive outcomes differs between fresh and frozen embryo transfer (FET) cycles....

(This article belongs to the Special Issue Cellular Immunology at the Maternal–Fetal Interface)
  • Article
  • Open Access
400 Views
10 Pages

Central tolerance is provided by the autoimmune regulator (AIRE) expressing medullary thymic epithelial cells through high-avidity recognition of self-antigens. Peripheral mechanisms regulate adaptive immunity by deleting autoreactive T-cells that es...

(This article belongs to the Special Issue Insights into the Pathogenesis of Autoimmune Diseases)

of 6